» Articles » PMID: 18256323

Itch-/- Alphabeta and Gammadelta T Cells Independently Contribute to Autoimmunity in Itchy Mice

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2008 Feb 8
PMID 18256323
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

E3 ubiquitin ligases determine which intracellular proteins are targets of the ubiquitin conjugation pathway and thus play a key role in determining the half-life, subcellular localization and/or activation status of their target proteins. Itchy mice lack the E3 ligase, Itch, and show dysregulation of T lymphocytes and the induction of a lethal autoimmune inflammatory condition. Itch is widely expressed in hematopoietic and nonhematopoietic cells, and we demonstrate that disease is transferred exclusively by hematopoietic cells. Moreover, distinct manifestations of the autoimmune inflammatory phenotype are contributed by discrete populations of lymphocytes. The presence of Itch-deficient alphabeta T cells drives expansion of peritoneal B1b cells and elevated IgM levels, which correlate with itching and pathology. In contrast, Itch(-/-) interleukin-4-producing gammadelta T cells, even in the absence of alphabeta T cells, are associated with elevated levels of IgE and an inflammatory condition. These data indicate that disruption of an E3 ubiquitin ligase in alphabeta T cells can subvert a B-cell subpopulation, which normally functions to control particular microbial pathogens in a T-independent manner, to contribute to autoimmunity. In addition, disruption of Itch in innate gammadelta T cells can influence autoimmune pathology and might therefore require distinct therapeutic intervention.

Citing Articles

The Ubiquitin Ligase Itch Skews Light Zone Selection in Germinal Centers.

Renshaw L, Kim P, Crici M, Fazelinia H, Spruce L, Oliver P J Immunol. 2023; 210(10):1473-1481.

PMID: 36929899 PMC: 10159933. DOI: 10.4049/jimmunol.2200824.


E3-ubiquitin ligases and recent progress in osteoimmunology.

Asano Y, Matsumoto Y, Wada J, Rottapel R Front Immunol. 2023; 14:1120710.

PMID: 36911671 PMC: 9996189. DOI: 10.3389/fimmu.2023.1120710.


ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction.

Wolfe R, Heiman P, DAnnibale O, Karunanidhi A, Powers A, Mcguire M Mol Genet Metab Rep. 2022; 33:100932.

PMID: 36338154 PMC: 9634006. DOI: 10.1016/j.ymgmr.2022.100932.


CircRNA ITCH: Insight Into Its Role and Clinical Application Prospect in Tumor and Non-Tumor Diseases.

Liu T, Huang T, Shang M, Han G Front Genet. 2022; 13:927541.

PMID: 35910224 PMC: 9335290. DOI: 10.3389/fgene.2022.927541.


Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation.

Bigley T, Cooper M Curr Opin Immunol. 2021; 72:230-238.

PMID: 34265589 PMC: 8452259. DOI: 10.1016/j.coi.2021.06.013.


References
1.
Majeti R, Xu Z, Parslow T, Olson J, Daikh D, Killeen N . An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell. 2001; 103(7):1059-70. DOI: 10.1016/s0092-8674(00)00209-9. View

2.
Casola S, Otipoby K, Alimzhanov M, Humme S, Uyttersprot N, Kutok J . B cell receptor signal strength determines B cell fate. Nat Immunol. 2004; 5(3):317-27. DOI: 10.1038/ni1036. View

3.
McGill M, McGlade C . Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem. 2003; 278(25):23196-203. DOI: 10.1074/jbc.M302827200. View

4.
Hardy R, Hayakawa K . A developmental switch in B lymphopoiesis. Proc Natl Acad Sci U S A. 1991; 88(24):11550-4. PMC: 53173. DOI: 10.1073/pnas.88.24.11550. View

5.
Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S . Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 1995; 3(5):549-60. DOI: 10.1016/1074-7613(95)90126-4. View